Skip to main content
OpenTrials

Clinical trial condition

Nervous System Neoplasms

Explore clinical trials studying Nervous System Neoplasms. Study availability and eligibility vary by location and protocol.

2,886 public trials 685 recruiting studies
Refine in advanced search Browse all conditions

Nervous System Neoplasms trial results

Active, Not Recruiting

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

NCT06413706

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations
  • Children's Hospital of Orange County - Orange Orange, California, United States
  • Lucile Packard Children's Hospital (LPCH) - Stanford University Palo Alto, California, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • The Johns Hopkins Hospital (JHH) - Johns Hopkins Childrens Center Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

NCT03423628

Conditions
Astrocytoma, Behavior, Brain Diseases, +31 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

NCT03220646

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas

NCT03962543

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations
  • University of Alabama at Birmingham/Children's of Alabama Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 43 locations
View Trial Details
Active, Not Recruiting

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

NCT04711824

Conditions
Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Memorial Healthcare System Hollywood, Florida, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions